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Background and purpose: Magnetization transfer imaging detects cerebral microstructural tissue alter-
ations. We examined the association between the Framingham Stroke Risk Proﬁle (FSRP) score and
magnetization transfer imaging (MTI) measures in pathological and normal appearing brain tissue in
clinically normal elderly subjects to determine if stroke risk leads to brain tissue destruction beyond
what is visible in conventional MRI scans.
Methods: The study cohort is from the Austrian Stroke Prevention Study (ASPS). A total of 316 subjects
underwent MTI and had a complete risk factor assessment sufﬁcient to calculate the FSRP score. There
were 205 women and 111menwith a mean age of 70.2 years ranging from 54 to 82 years. Subjects were
grouped into four categories of stroke risk probability ranging from 3% to 88% for men and 1% to 84% for
women.
Results: A higher FSRP score was signiﬁcantly and independently associated with a MTR peak position
shift indicating globalmicrostructural alterations in brain tissue (BT) and innormal appearingbrain tissue
(NABT). The mean MTR in white matter hyperintensities (WMH) correlated inversely with increasing
stroke risk. Age explained most of the variance in MTR peak position, all other risk factors of the FSRP
score contributed signiﬁcantly but explained an additional 2% of the variance of this MRI measure, only.
Conclusion: Increasing risk for stroke leads to microstructural brain changes invisible by standard MRI.
The validity, the underlying pathogenic mechanisms and the clinical importance of these abnormalities
mineneeds to be further deter
. Introduction
Conventional MRI detects accumulation of brain tissue destruc-
ion with advancing age and increased stroke risk [1]. “Silent”
esions include white matter abnormalities, lacunes and less com-
only thromboembolic infarcts [2,3]. Recent diffusion tensor
maging (DTI) studies reported increased stroke risk to result in
icrostructural cerebral damage invisible on standard MR scans.
he data show an association between blood pressure and white
atter microstructure integrity in several regions of the brain in
ealthy adults [4]. Accordingly, Kennedy and Raz [5] reported that
ncreasing pulse pressure leads to loss of anterior white matter
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integrity and another investigation by Gons et al. [6] revealed
that hypertension-related DTI changes in normal appearing white
matter preceeded morphological lesion. Microstructural tissue
alterations are not only detectable by DTI but also by magneti-
zation transfer imaging (MTI). MTI is based on the exchange of
magnetization between tissue water and protons that are bound
to macromolecules such as myelin lipids and proteins. The rate
of exchange gives an estimate of the magnitude of these com-
partments, such as the pool of bound protons. The efﬁcacy of
magnetization transfer is usually quantiﬁed by the magnetiza-
tion transfer ratio (MTR) which is considered to largely reﬂect the
myelin content of the investigated brain regions [7].MTR decreases
with advancing age. As to whether stroke risk per se also leads to
MTR-detectablemicrostructural brain changes is widely unknown.
Open access under CC BY-NC-ND license. Wehypothesized that an increased FraminghamStroke Risk Proﬁle
Score (FSRP) which estimates the 10-year probability for incident
stroke in stroke-free individuals [8] relates to a decrease in MTR
metrics of normal appearing brain tissue (NABT) independently of
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oncomitant visible tissue damage. We tested this hypothesis in a
ample of 316 participants of the Austrian Stroke Prevention Study.
. Methods
.1. Subjects
The study cohort consists of participants of the Austrian Stroke
revention Study (ASPS) a single-center prospective follow-up
tudy in residents of the city of Graz, Austria. The ASPS examines
he frequency of cerebrovascular risk factors and their effect on
erebral morphology and function in the normal elderly. The study
esign and methods have been described previously [9,10]. On the
asis of a structured clinical interview and a physical and neu-
ologic examination, participants were free of overt neurologic
r psychiatric disease including previous cerebrovascular attacks
nd dementia. A randomly selected sub-sample of 1073 ASPS par-
icipants took part in neuroimaging studies including brain MRI.
nrollment into theMR study of ASPSwas started in 1991. Between
001 and 2005MTIwas added to the scanning protocol. During this
ime period a total of 372 subjects entered the study. All of them
nderwent MTI. For the current investigation we included those
16 subjects (205 women, 111 men; mean age 70.2 years; range
4–82 years) who underwent both MTI scanning and a complete
isk factor assessment according to the FSRP. The study protocol
as approved and accepted by the ethics committee of the Medi-
al University of Graz, Austria, and informed consent was obtained
rom all study participants.
.2. Vascular risk factors
Risk factors were determined based on the participants’ history
nd ﬁndings at the examination as previously described [10]. Dia-
etes was considered if a subject was treated for diabetes at the
ime of examination or if the fasting blood glucose level was above
26mg−1 dl−1 at the timeof examination. Bloodpressurewasmea-
ured by a random-zero sphygmomanometer, after 5min of rest,
ndat the endof the studyvisit. Themeanof the twomeasurements
as used. Subjects were classiﬁed as former, current smokers or
on-smokers. Cardiac disease was assumed to be present if there
as an evidence of cardiac abnormalities known to be a source of
erebral embolism, evidence of coronary heart disease according
o the Rose questionnaire or appropriate ECG ﬁndings (Minnesota
odes: III, 1–3, IV, 1–3; or V, 1–2) or if individual presented signs
f left ventricular hypertrophy on echocardiography or ECG (Min-
esota codes: III, 1; or IV, 1–3). Atrial ﬁbrillation was diagnosed
ased on electrocardiogram ﬁndings obtained at the study visit.
.3. Framingham Stroke Risk Proﬁle (FSRP)
The Framingham stroke risk predicts the probability of inci-
ent strokes within 10 years in stroke-free individuals and was
alculated as described [8]. Brieﬂy, the risk factors included in
he FSRP are age, systolic blood pressure, use of antihypertensive
edication, diabetes, smoking status, cardiovascular disease, atrial
brillation, and left ventricular hypertrophy. The FSRP provides
peciﬁc risk estimates formen andwomen. The score ranges from1
o 30 points formen and 1 to 27 points for women. The sex-speciﬁc
core is then converted to 10 year probability of strokes ranging
rom 3% to 88% for men and 1% to 84% for women.
.4. Conventional MRIThe MRI methodology used in the Austrian Stroke Preven-
ion Study has been described [10,11]. MRI was performed on
.5-T magnets (Gyroscan S 15 and ACS, Philips, Eindhoven, TheNeurosurgery 115 (2013) 1317–1321
Netherlands) using proton density- and T2-weighted sequences
(repetition time [TR]/echo time [TE], 2000–2500ms/30–90ms) in
the transverse orientation. T1-weighted images (TR/TE, 600/30ms)
were generated in the sagittal plane. The slice thickness was 5mm
and the imagematrixwas 128×256pixels. The scanning planewas
always determined by a sagittal and coronal pilot scan to ensure
consistency in image angulation throughout the study [10]. White
matter hyperintensities (WMH) were speciﬁed and graded by the
Fazekas Score [12] into absent (grade 0) punctuate (grade 1), early
conﬂuent (grade 2) and conﬂuent (grade 3) WMH, and semiau-
tomated WMH volume measurements were done as described in
previous publications [13]. Scans were also analyzed for the pres-
enceof clinically silent cortical infarcts and lacunes.Cortical infarcts
were lesions that had consistent signal characteristics involving the
cortex and following a typical branch pattern [14,15]. Lacuneswere
focal lesions isointense to CSF involving the basal ganglia, thewhite
matter, the internal capsule, the thalamus or the brainstem ranging
in maximal diameter between 3mm and 10mm [16].
2.5. Magnetization transfer imaging (MTI)
MTI was performed after conventional MR imaging with a
spoiled 3D gradient-echo sequence (TE=4ms, TR=26ms, FA=20◦,
section thickness =3mm, FOV=250mm, matrix =256×256) with
and without a binomial saturation pulse (90–180–90◦, maximum
amplitude=21T) covering the whole brain. MTR maps were cal-
culated according to the formula MTR= (Mss-Mo)/Mo, where Mss
andMoare the signal intensities obtainedwith andwithoutMT sat-
uration, respectively. Then they were registered to the FLAIR scans
using an automated afﬁne registration tool (FLIRT, FMRIB Image
Analysis Group Oxford).
MTR metrics were assessed for the whole brain tissue (BT)
including the cerebellum and the brain stem. They were also
recorded in normal appearing brain tissue (NABT) which was
all brain tissue outside WMH and lacunes as well as for WMH.
The deﬁnition of NABT and assessment of WMH were based on
FLAIR scans. A mean MTR was calculated for each WMH by mask-
ing the registered MTR maps with the WMH masks. To reduce
partial volume effects, which might have taken place due to
image registration and subsequent interpolation, we eroded all
WMH masks by 1 pixel. The MTR of all WMH was averaged
to obtain a mean lesional MTR for each subject. MTR data in
WMH follow a Gaussian distribution. Therefore mean MTR is the
appropriate measure to describe lesional MTR data. To analyze
the MTR metrics of NABT and BT, MTR maps were masked out
with the WMH masks after dilating them by 1 pixel and after
removing nonbrain tissue with a brain extraction tool (BET as
a part of FSL, http://www.Fmnb.ox.ac.uk/fsl/bet2/index.html). All
remaining voxels in the MTR maps were then considered for the
MTRhistogramanalysis. For eachhistogram,wecalculated thepeak
position (i.e. theMTRvaluewith the highest frequency) and the rel-
ative peak height (i.e. the relative voxel count at the peak position).
Mean MTR in NABT is not displayed because the MTR histogram of
this tissue compartment does not followaGaussian distribution. To
correct for differences in individual brain volumes, we normalized
the histograms by the total number of voxels contributing to the
histogram [17,18].
2.6. Statistical analysis
Multiple linear regression analysis was used to correlate the
FSRP score with MTRmetrics. The analyses were adjusted for pres-
ence of lacunes, and cortical infarcts as well as for white matter
hyperintensity volume. In separate analyses adjustment was also
done for number of lacunes and cortical infarcts. For each regres-
sion coefﬁcient, the 95% conﬁdence interval and the p-value were
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Table 1
Demographics, risk factors and MRI ﬁndings in categories of increasing Framingham Stroke Risk Proﬁle Scores.
Category 1 Category 2 Category 3 Category 4
10-year stroke risk probability, % <11 11–20 21–30 >30
N 73 110 63 70
A. Risk factors
Age, years 66.8±5.8 69.8±5.8 71.4±5.8 73.8±5.3
Sex w/m, N (%) 39/34 (53.4/46.6) 70/40 (63.6/36.4) 44/19 (69.8/30.2) 52/18 (74.3/25.7)
Systolic blood pressure, mmHg 129.6±27.9 145.2±19.2 162.1±19.3 169.8±22.8
Diabetes mellitus, N (%) 3 (4.6) 7 (6.4) 7 (11.1) 25 (35.7)
Cigarette smoking, N (%) 18 (24.7) 37 (33.6) 24 (38 .1) 32 (45.7)
Cardiovascular disease, N (%) 4 (5.5) 26 (23.6) 26 (41.3) 51 (72.8)
Atrial ﬁbrillation, N (%) 0 0 1 (1.6) 12 (17.1)
Left ventricular hypertrophy, N (%) 0 1 (0.9) 2 (3.4) 5 (7.6)
Antihypertensive therapy, N (%) 6 (8.2) 30 (27.3) 30 (47.6) 47 (67.1)
B. MRI
WMH, cm3, mean± SD (range) 1.8±3.5 (0–23.4) 4.8±9.9 (0–78) 4.2±5.3 (0–21.4) 6.5±9.2 (0–52.5)
Presence of lacunes, N (%) 6 (9.2) 5 (4.6) 3 (4.8) 7 (10.1)
Number of lacunes, mean± SD (range) 0.1±0.3 (0–2) 0.1±0.8 (0–6) 0.0±0.3 (0–2) 0.2±0.7 (0–5)
Presence of cortical infarcts, N (%) 1 (1.5) 5 (4.5) 0 4 (5.8)
Number of Cortical infarcts, mean± SD (range) 0.0±0.1 (0–1) 0.0±0.3 (0–3) 0 0.0±0.2 (0–1)
D sk factors deﬁned in the text. MRI, Magnetic Resonance Imaging; WMH, White Matter
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Table 2
Multiple linear regression analysisa: FSRP and MTR metrics in different tissue
segments.
ˇ 95% CI p
MTR in BT
Peak position −0.022 [−0.032, −0.013] <0.001
Peak height −3.36e−5 [−7.4e−5, 6.5e−6] 0.1
MTR in NABT
Peak position −0.021 [−0.031, −0.012] <0.001
Peak height −3.04e−5 [−7.0e−5, 9.5e−6] 0.135
MTR of WMH
Mean −0.025 [−0.044, −0.006] 0.011
Small numbers are displayed in exponential format. FSRP, Framingham Stroke
Risk Proﬁle; MTR, Magnetization Transfer Ratio; BT, Brain Tissue; NABT, normal
appearing brain tissue; WMH, White Matter Hyperintensities. ˇ, regression coefﬁ-
severity of MTI-detected microstructural tissue changes in BT,
NABT and WMH in middle-aged and elderly subjects without clin-
ical signs or symptoms of neurologic disease. Higher FSRP scores
shifted the MTR peak to the left without affecting peak height. The
Table 3
Proportion of total variance in peak position in BT and NABT explained by age alone
and explained by all the other FSRP risk factors together (beyond the age explained
variance).
BT NABT
Agea 17% (p-value <0.001) 15% (p-value <0.001)
FSRP risk factors except age 2% (p-value =0.029) 2% (p-value =0.035)ata are mean± SD, N (%), percentages are based on the individual categories. Ri
yperintensities; SD, standard deviation.
etermined. Three different models were assessed for NABT, BT,
nd WMH. The ﬁrst model contained the 10-year probability of
troke risk as the independent variable.
For model 2, all subjects were grouped into four categories
epending on their stroke risk probability, <11% (category 1),
1–20% (category 2), 21–30% (category 3) and >30% (category 4).
he characteristics of participants in each category are shown in
able 1. These categories were used as explanatory variables to
etermine a possible dose–response relationship. The third model
ncluded each single risk factor to assess its independent contri-
ution on MTR metrics. For signiﬁcantly related risk factors the
roportion of MTR variance explained by the given risk factor was
etermined. We also identiﬁed the proportion of variance that is
xplained by all the other risk factors compiled when themost sig-
iﬁcant risk factor is already in themodel. Therefore, the difference
etween the adjusted coefﬁcients of determination (R2) of model
and a model including only the given risk factor was computed.
n F-test was used to assess the signiﬁcance of R2 and the change
n R2. As the study is explorative, no corrections for multiple test-
ng have been made [19]. All analyses were performed using Stata
Stata Statistical Software, release 6; StataCorp, College Station,
X). A two-sided p-value <0.05 was considered to be statistically
igniﬁcant.
. Results
As can be seen from Table 2, the FSRP score was signiﬁcantly
nd independently associatedwithMTR peak position but notwith
eak height in BT and in NABT. A higher FSRP score shifted theMTR
eak to the left. The associations remained virtually unchanged
hen adjustment was made for number of cortical infarcts and
umber of lacunes insteadof presence or absence of these lesions. A
igher FSRP scorewasalso related todecreasedmeanMTR inWMH.
ig. 1 demonstrates the association between categories of increas-
ng stroke risk and MTR peak position in BT and NABT, as well as
ean MTR in WMH. The ﬁgure reveals an almost linear inverse
elationship between increasing risk of stroke and MTR metrics.
When considering the relationship between the single compo-
ents of the FSRP and MTR peak position and we identiﬁed age
s the only signiﬁcant risk factor for the shift in MTR peak posi-
ion in BT and NABT (data not shown). Systolic blood pressure was
ot related to MTR metrics when used as a continuous variable
ut when the quartile distribution of systolic blood pressure was
sed the associations with peak position in BT and NABT becamecient; CI, conﬁdence interval.
a Adjusted for presence of lacunes, cortical infarcts,whitematter hyperintensities
volume.
signiﬁcant (p for trend <0.014 and <0.02, respectively). An inverse
relationship with MTR peak position was only seen at systolic
blood pressure values ≥151mm Hg. Age explained the majority
of the total variance in MTR peak position. The contribution of
the remaining FSRP risk factors was statistically signiﬁcant. They
explained only 2% of the variance beyond what was explained by
age alone (Table 3).
4. Discussion
Our data show that increasing stroke risk correlates with theFSRP, Framingham Stroke Risk Proﬁle; BT, Brain Tissue; NABT, normal appearing
brain tissue.
a Adjusted for presence of lacunes, cortical infarcts,whitematter hyperintensities
volume. Risk factors deﬁned in the text.
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Fig. 1. Relationship betweenMTR peak position in BT (left panel) and NABT (middle panel) as well as MTR ofWMH (right panel), and the categories of stroke risk probability
(indicated on the y-axis). Regression analysis with the categories coded as dummy variables shows a left shift of the MTR peak in higher categories compared to category
1 in BT peak position (category 2: ˇ =−0.25, 95% CI [−0.64 to 0.13]; category 3: ˇ =−0.39, 95% CI [−0.83 to 0.04]; category 4: ˇ =−0.80, 95% CI [−1.22 to −0.34]), and NABT
peak position (category 2: ˇ =−0.29, 95% CI [−0.69 to 0.09]; category 3: ˇ =−0.41, 95% CI [−0.85 to 0.03]; category 4: ˇ =−0.81, 95% CI [−1.25 to −0.37]) as well as a decrease
i 5% CI
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[n WMH MTR (category 2: ˇ =−0.36, 95% CI [−1.18 to 0.44]; category 3: ˇ =−0.76, 9
-axis indicate the ˇ-coefﬁcients and the bars indicate 95% CIs.
ffect was predominantly age-related, major vascular risk factors
ontributed signiﬁcantly but their joint effect onMTRpeak position
as small.
Peak height and peak position together provide complementary
iews onmicrostructural tissue changes. The peak in the histogram
epresents the largest tissue component, i.e.whitematter. Thepeak
eight therefore reﬂects the relative number of voxels representing
hite matter [20]. Consequently, a decrease in peak height indi-
ates focal tissue changes rather than global and diffuse alterations.
y contrast, peakposition is indicative of global anddiffuse changes
n thewhitematter. A shift to the left in BT and NABT as seen in our
tudy suggests a global decrease of MTR in the white matter with
emyelinationbeing themost likely histopathological correlate [7].
Previous studies reported that the FSRP and cardiovascular risk
actors were related to white matter hyperintensities volume [2]
nd the FraminghamOffspring Study showed a positive correlation
ith silent cerebral infarcts [3].
Our study extents these results as we have shown that increas-
ng stroke risk does not only lead to structural but also to
icrostructural tissue destruction as determined byMTI. This ﬁnd-
ng is corroborated by a previous report relating hypertension and
iabetes to MTR metrics in NABT [18]. Importantly, a higher FSRP
as also related to adecreasedMTR inWMHindicating that the risk
roﬁle of study participants also inﬂuenced the severity of tissue
estruction in ischemic lesions visible on standard MRI sequences.
Our study has several strengths. We included a large number of
ealthy study participants and used a MTI protocol including a 3D
equence with a high repetition rate of the MT saturation pulses.
e used ultra short (1ms) binomial MT saturation pulses and
hort interpulse delay, which produce a higher saturation effect.
ur study design was prospective and we used a standardized
rotocol. Limitations of our investigation are its cross sectional
esign and the relative small variability of MTR metrics occurring
n asymptomatic individuals. Because of the limited resolution, we
efrained from segmenting the cortex as thiswould have otherwise
ntroduced partial volume effects.
The validity, the underlying pathogenic mechanisms and the
linical importance of microstructural brain abnormalities in the
ake of an increased stroke risk score needs to be further explored.
e realize full well that the FSRP can only be considered as a sur-
ogate of stroke risk, and a longitudinal study design would have
een necessary to determine the actual risk for stroke in our study
articipants. A longitudinal design will also clarify the sequence
f MRI ﬁndings in relation to clinical symptoms. We hypothesize
hat microstructural changes occur at the earliest risk stages fol-
owed by visible clinically silent brain abnormalities and ultimately
[[−1.66 to 0.12]; category 4: ˇ =−0.94, 95% CI [−1.85 to −0.04]). The squares on the
clinical symptoms. Our study results that FSRP risk components
were signiﬁcantly related to MTR metrics but explained only 2% of
their variance suggest a rather limited role of this method in the
prediction of future stroke risk.
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